{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:47:10Z","timestamp":1791136030741,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,2,24]],"date-time":"2012-02-24T00:00:00Z","timestamp":1330041600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s00345-012-0842-0","type":"journal-article","created":{"date-parts":[[2012,2,23]],"date-time":"2012-02-23T06:45:02Z","timestamp":1329979502000},"page":"333-339","source":"Crossref","is-referenced-by-count":21,"title":["AR-Q640X, a model to study the effects of constitutively active C-terminally truncated AR variants in prostate cancer cells"],"prefix":"10.1007","volume":"30","author":[{"given":"Wolfgang","family":"Streicher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedemann","family":"Zengerling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Laschak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Weidemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"H\u00f6pfner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres J.","family":"Schrader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Jentzmik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schrader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus V.","family":"Cronauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,24]]},"reference":[{"issue":"2","key":"842_CR1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69\u201390","journal-title":"CA Cancer J Clin"},{"key":"842_CR2","first-page":"3068","volume":"55","author":"A Hobisch","year":"1995","unstructured":"Hobisch A, Culig Z, Radmayr C, Bartsch G, Klocker H, Hittmair A (1995) Distant metastases from prostatic carcinoma express androgen receptor protein. Cancer Res 55:3068\u20133072","journal-title":"Cancer Res"},{"key":"842_CR3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/(SICI)1097-0045(199602)28:2<129::AID-PROS9>3.0.CO;2-B","volume":"28","author":"A Hobisch","year":"1996","unstructured":"Hobisch A, Culig Z, Radmayr C, Bartsch G, Klocker H, Hittmair A (1996) Androgen receptor status of lymph node metastases from prostate cancer. Prostate 28:129\u2013135","journal-title":"Prostate"},{"key":"842_CR4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/ng0495-401","volume":"9","author":"T Visakorpi","year":"1995","unstructured":"Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Kein\u00e4nen R, Palmberg C, Palotie A, Tammela T, Isola J, Kallioniemi OP (1995) In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet 9:401\u2013406","journal-title":"Nat Genet"},{"key":"842_CR5","first-page":"1095","volume":"23","author":"MV Cronauer","year":"2003","unstructured":"Cronauer MV, Schulz WA, Burchardt T, Anastasiadis AG, de la Taille A, Ackermann R, Burchardt M (2003) The androgen receptor in hormone-refractory prostate cancer: relevance of different mechanisms of androgen receptor signaling. Int J Oncol 23:1095\u20131102","journal-title":"Int J Oncol"},{"key":"842_CR6","author":"N Nadiminty","year":"2011","unstructured":"Nadiminty N, Gao AC (2011) Mechanisms of persistent activation of the androgen receptor in CRPC: recent advances and future perspectives. World J Urol. doi: 10.1007\/s00345-011-0771-3","journal-title":"World J Urol"},{"key":"842_CR7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ijc.11404","volume":"108","author":"J C\u00e9raline","year":"2004","unstructured":"C\u00e9raline J, Cruchant MD, Erdmann E, Erbs P, Kurtz JE, Duclos B, Jacqmin D, Chopin D, Bergerat JP (2004) Constitutive activation of the androgen receptor by a point mutation in the hinge region: a new mechanism for androgen-independent growth in prostate cancer. Int J Cancer 108:152\u2013157","journal-title":"Int J Cancer"},{"key":"842_CR8","doi-asserted-by":"crossref","first-page":"9001","DOI":"10.1158\/0008-5472.CAN-07-1072","volume":"67","author":"SJ Libertini","year":"2007","unstructured":"Libertini SJ, Tepper CG, Rodriguez V, Asmuth DM, Kung HJ, Mudryj M (2007) Evidence for calpain-mediated androgen receptor cleavage as a mechanism for androgen independence. Cancer Res 67:9001\u20139005","journal-title":"Cancer Res"},{"key":"842_CR9","doi-asserted-by":"crossref","first-page":"5469","DOI":"10.1158\/0008-5472.CAN-08-0594","volume":"68","author":"SM Dehm","year":"2008","unstructured":"Dehm SM, Schmidt LJ, Heemers HV, Vessella RL, Tindall DJ (2008) Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance. Cancer Res 68:5469\u20135477","journal-title":"Cancer Res"},{"key":"842_CR10","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1007\/s00018-011-0766-7","volume":"68","author":"S Haile","year":"2011","unstructured":"Haile S, Sadar MD (2011) Androgen receptor and its splice variants in prostate cancer. Cell Mol Life Sci 68:3971\u20133981","journal-title":"Cell Mol Life Sci"},{"key":"842_CR11","doi-asserted-by":"crossref","first-page":"5913","DOI":"10.1158\/1078-0432.CCR-11-0728","volume":"17","author":"EA Mostaghel","year":"2011","unstructured":"Mostaghel EA, Marck BT, Plymate SR, Vessella RL, Balk S, Matsumoto AM, Nelson PS, Montgomery RB (2011) Resistance to CYP17A1 inhibition with abiraterone in castration-resistant prostate cancer: induction of steroidogenesis and androgen receptor splice variants. Clin Cancer Res 17:5913\u20135925","journal-title":"Clin Cancer Res"},{"key":"842_CR12","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1172\/JCI41824","volume":"120","author":"S Sun","year":"2010","unstructured":"Sun S, Sprenger CC, Vessella RL, Haugk K, Soriano K, Mostaghel EA, Page ST, Coleman IM, Nguyen HM, Sun H, Nelson PS, Plymate SR (2010) Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant. J Clin Invest 120:2715\u20132730","journal-title":"J Clin Invest"},{"key":"842_CR13","doi-asserted-by":"crossref","first-page":"16759","DOI":"10.1073\/pnas.1012443107","volume":"107","author":"PA Watson","year":"2010","unstructured":"Watson PA, Chen YF, Balbas MD, Wongvipat J, Socci ND, Viale A, Kim K, Sawyers CL (2010) Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor. Proc Natl Acad Sci USA 107:16759\u201316765","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"842_CR14","doi-asserted-by":"crossref","first-page":"e25341","DOI":"10.1371\/journal.pone.0025341","volume":"6","author":"SV Sch\u00fctz","year":"2011","unstructured":"Sch\u00fctz SV, Schrader AJ, Zengerling F, Genze F, Cronauer MV, Mark Schrader M (2011) Inhibition of Glycogen Synthase Kinase-3\u03b2 counteracts ligand-independent activity of the androgen receptor in castration resistant prostate cancer. PLoS ONE 6(9):e25341. doi: 10.1371\/journal.pone.0025341","journal-title":"PLoS ONE"},{"key":"842_CR15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/pros.20059","volume":"59","author":"DJ Mulholland","year":"2004","unstructured":"Mulholland DJ, Cox M, Read J, Rennie P, Nelson C (2004) Androgen responsiveness to renilla luciferase reporter vectors is promoter, transgene, and cell line dependent. Prostate 59:115\u2013119","journal-title":"Prostate"},{"key":"842_CR16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1210\/me.7.1.23","volume":"7","author":"PS Rennie","year":"1993","unstructured":"Rennie PS, Bruchovsky N, Leco KJ, Sheppard PC, McQueen SA, Cheng H, Snoek R, Hamel A, Bock ME, MacDonald BS, Nickel BE, Chang C, Liao S, Cattini PA, Matusik RJ (1993) Characterization of two cis-acting DNA-elements involved in the androgen regulation of the probasin gene. Mol Endocrinol 7:23\u201336","journal-title":"Mol Endocrinol"},{"key":"842_CR17","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1210\/mend-5-10-1396","volume":"5","author":"G Jenster","year":"1991","unstructured":"Jenster G, van der Korput HA, van Vroonhoven C, van der Kwast TH, Trapman J, Brinkmann AO (1991) Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization. Mol Endocrinol 5:1396\u20131404","journal-title":"Mol Endocrinol"},{"key":"842_CR18","first-page":"6606","volume":"62","author":"CG Tepper","year":"2002","unstructured":"Tepper CG, Boucher DL, Ryan PE, Ma AH, Xia L, Lee LF, Pretlow TG, Kung HJ (2002) Characterization of a novel androgen receptor mutation in a relapsed CWR22 prostate cancer xenograft and cell line. Cancer Res 62:6606\u20136614","journal-title":"Cancer Res"},{"key":"842_CR19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1158\/0008-5472.CAN-08-2764","volume":"69","author":"R Hu","year":"2009","unstructured":"Hu R, Dunn TA, Wei S, Isharwal S, Veltri RW, Humphreys E, Han M, Partin AW, Vessella RL, Isaacs WB, Bova GS, Luo J (2009) Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer. Cancer Res 69:16\u201322","journal-title":"Cancer Res"},{"key":"842_CR20","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1158\/0008-5472.CAN-08-3795","volume":"69","author":"Z Guo","year":"2009","unstructured":"Guo Z, Yang X, Sun F, Jiang R, Linn DE, Chen H, Chen H, Kong X, Melamed J, Tepper CG, Kung HJ, Brodie AM, Edwards J, Qiu Y (2009) A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth. Cancer Res 69:2305\u20132313","journal-title":"Cancer Res"},{"issue":"4","key":"842_CR21","doi-asserted-by":"crossref","first-page":"e19059","DOI":"10.1371\/journal.pone.0019059","volume":"6","author":"E H\u00f6rnberg","year":"2011","unstructured":"H\u00f6rnberg E, Ylitalo EB, Crnalic S, Antti H, Stattin P, Widmark A, Bergh A, Wikstr\u00f6m P (2011) Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival. PLoS One 6(4):e19059. doi: 10.1371\/journal.pone.0019059","journal-title":"PLoS One"},{"issue":"11","key":"842_CR22","doi-asserted-by":"crossref","first-page":"e27970","DOI":"10.1371\/journal.pone.0027970","volume":"6","author":"X Zhang","year":"2011","unstructured":"Zhang X, Morrissey C, Sun S, Ketchandji M, Nelson PS, True LD, Vakar-Lopez F, Vessella RL, Plymate SR (2011) Androgen receptor variants occur frequently in castration resistant prostate cancer metastases. PLoS One 6(11):e27970. doi: 10.1371\/journal.pone.0027970","journal-title":"PLoS One"},{"key":"842_CR23","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/pros.21382","volume":"71","author":"R Hu","year":"2011","unstructured":"Hu R, Isaacs WB, Luo J (2011) A snapshot of the expression signature of androgen receptor splicing variants and their distinctive transcriptional activities. Prostate 71:1656\u20131667","journal-title":"Prostate"},{"key":"842_CR24","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/978-0-387-69080-3_53","volume":"617","author":"G Lapouge","year":"2008","unstructured":"Lapouge G, Marcias G, Erdmann E, Kessler P, Cruchant M, Serra S, Bergerat JP, C\u00e9raline J (2008) Specific properties of a C-terminal truncated androgen receptor detected in hormone refractory prostate cancer. Adv Exp Med Biol 617:529\u2013534","journal-title":"Adv Exp Med Biol"},{"key":"842_CR25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/humu.20848","volume":"30","author":"JP Bergerat","year":"2009","unstructured":"Bergerat JP, C\u00e9raline J (2009) Pleiotropic functional properties of androgen receptor mutants in prostate cancer. Hum Mutat 30:145\u2013157","journal-title":"Hum Mutat"},{"key":"842_CR26","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ccr.2010.04.027","volume":"17","author":"RJ Andersen","year":"2010","unstructured":"Andersen RJ, Mawji NR, Wang J, Wang G, Haile S, Myung JK, Watt K, Tam T, Yang YC, Banuelos CA, Williams DE, McEvan IJ, Wang Y, Sadar MD (2010) Regression of castrate- recurrent prostate cancer by small molecule inhibitor of the amino-terminus domain of the androgen receptor. Cancer Cell 17:535\u2013546","journal-title":"Cancer Cell"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-012-0842-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-012-0842-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-012-0842-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:40:02Z","timestamp":1559050802000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-012-0842-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,24]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["842"],"URL":"https:\/\/doi.org\/10.1007\/s00345-012-0842-0","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,24]]}}}